| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/08/2013 | US20130202570 Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof |
| 08/08/2013 | US20130202569 Transgenic Ungulates Expressing CTLA4-IG and Uses Thereof |
| 08/08/2013 | US20130202564 Systems and Methods of Cell Activated, Controlled Release Delivery of Growth Factors for Tissue Repair and Regeneration |
| 08/08/2013 | US20130202560 Pharmaceutical composition for cancer prevention and treatment containing the c12orf59 gene or protein as an active ingredient |
| 08/08/2013 | US20130202556 Treatment of Hepatitis C Virus Related Diseases Using Hydroxychloroquine or a Combination of Hydroxychloroquine and an Anti-Viral Agent |
| 08/08/2013 | US20130202553 Mobilization of hematopoietic stem cells |
| 08/08/2013 | US20130202552 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 08/08/2013 | US20130202533 Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination |
| 08/08/2013 | US20130199519 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 08/08/2013 | DE112011103711T5 Caspofungin-Analogen Herstellungsverfahren dafür und Verwendung desselben The same caspofungin analogs manufacturing method thereof and use |
| 08/08/2013 | DE102012020045A1 Chymotrypsin-Lösung Chymotrypsin solution |
| 08/07/2013 | EP2623611A1 Method for purifying cyclic lipopeptide or salt thereof |
| 08/07/2013 | EP2623605A1 RAAV vector compositions having tyrosine-modified capsid proteins and methods for use |
| 08/07/2013 | EP2623601A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 08/07/2013 | EP2623512A1 Peptide capable of binding to immunoglobulin |
| 08/07/2013 | EP2623119A1 Glioma treatment method, glioma examination method, method of delivering a desired material to a glioma, and drug used in said methods |
| 08/07/2013 | EP2623113A2 Compounds For Enzyme Inhibition |
| 08/07/2013 | EP2623112A1 Soluble hybrid Fc gamma receptors and related methods |
| 08/07/2013 | EP2623111A2 Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition |
| 08/07/2013 | EP2623110A1 Factor XII inhibitors for the treatment of neurological inflammatory disorders |
| 08/07/2013 | EP2623109A1 Enteral nutrient |
| 08/07/2013 | EP2622971A1 Method for controlling the digestive coagulation of proteins |
| 08/07/2013 | EP2622090A1 Methods and compositions for inhibiting viral entry into cells |
| 08/07/2013 | EP2622088A2 Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins |
| 08/07/2013 | EP2622071A1 Polypeptides having endopeptidase activity and polynucleotides encoding same |
| 08/07/2013 | EP2621945A2 Nd2 peptides and methods of treating neurological disease |
| 08/07/2013 | EP2621944A2 Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9 |
| 08/07/2013 | EP2621537A1 Pentapeptide derivatives for promoting hair growth |
| 08/07/2013 | EP2621521A2 Minimizing intestinal dysfunction |
| 08/07/2013 | EP2621520A1 Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen |
| 08/07/2013 | EP2621519A2 Engineered polypeptides having enhanced duration of action |
| 08/07/2013 | EP2621518A2 Use of growth hormone to enhance the immune response in immunosuppressed patients |
| 08/07/2013 | EP2621517A1 Composition for controlled ovarian stimulation |
| 08/07/2013 | EP2621516A2 Interferon-beta for use as monotherapy or in combination with other cancer therapies |
| 08/07/2013 | EP2621515A2 Highly soluble leptins |
| 08/07/2013 | EP2621514A1 Compositions and methods for treatment of hematological malignancies |
| 08/07/2013 | EP2621513A1 Eph receptor expression in tumor stem cells |
| 08/07/2013 | EP2621512A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 08/07/2013 | EP2621511A1 Methods and pharmaceutical compositions for the treatment of bone density related diseases |
| 08/07/2013 | EP2621510A2 Anticancer agent |
| 08/07/2013 | EP2621509A2 Formulations of guanylate cyclase c agonists and methods of use |
| 08/07/2013 | EP2621508A1 N-carboxyalkyl auristatins and the use thereof |
| 08/07/2013 | EP2621507A1 Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof |
| 08/07/2013 | EP2621504A2 Personal care composition containing yeast extract and hexapeptide |
| 08/07/2013 | EP2621501A1 Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases |
| 08/07/2013 | EP2621478A2 Method of preparing a dry powder from a water bacteria extract-concentrate |
| 08/07/2013 | EP2621476A1 Enteric coated, low- strength pancrelipase formulations |
| 08/07/2013 | EP2621473A2 Method for removing residual organic solvent from microparticles |
| 08/07/2013 | EP2621469A2 Cyclosporine emulsion |
| 08/07/2013 | EP2621468A2 Pharmaceutical composition |
| 08/07/2013 | EP2621420A1 Corneal treatment system and method |
| 08/07/2013 | EP2621282A2 Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes |
| 08/07/2013 | CN1869217B Method for producing transgene protein medicine of mammary gland expression using gland virus as carrier mammary |
| 08/07/2013 | CN103237808A 抗癌融合蛋白 Anticancer fusion protein |
| 08/07/2013 | CN103237806A Peptide capable of binding to immunoglobulin |
| 08/07/2013 | CN103237558A Minimizing intestinal dysfunction |
| 08/07/2013 | CN103237557A Treatment of chronic nephropathies using soluble complement receptor type I (sCR1) |
| 08/07/2013 | CN103233019A Genetically engineered bacterium for efficiently expressing recombinant bacteriocin and construction method and application thereof |
| 08/07/2013 | CN103232979A Cyanea capillata thioredoxin and coding gene and application thereof |
| 08/07/2013 | CN103232978A Preparation method of plant SOD (superoxide dismutase) for treating burns and scalds through external application |
| 08/07/2013 | CN103232543A Recombinant protein Tumstatin-CD137L4 with Tumstatin activities as well as preparation method and application thereof |
| 08/07/2013 | CN103232542A Double-target chimeric protein |
| 08/07/2013 | CN103232539A Antibodies to opgl |
| 08/07/2013 | CN103232538A Sulfhydrylation modified collagen calcium compound |
| 08/07/2013 | CN103232537A Preparation method and use of mustelus griseus cartilage blood vessel generation inhibiting factor |
| 08/07/2013 | CN103232528A Bioactive polypeptide DELQ and preparation method and application thereof |
| 08/07/2013 | CN103232527A Bioactive polypeptide SLPQ and its preparation method and use |
| 08/07/2013 | CN103232526A Bioactive polypeptide LPLP, and preparation and application thereof |
| 08/07/2013 | CN103232381A Peptidomimetic protease inhibitors |
| 08/07/2013 | CN103230599A Protein drug delivery system for enhancing releasing of polypeptide drug from cell endosome and application thereof |
| 08/07/2013 | CN103230598A Fusion peptide therapeutic compositions |
| 08/07/2013 | CN103230589A Fibrinogen compound and application thereof |
| 08/07/2013 | CN103230588A Application of cholinesterase capable of hydrolyzing P substance at C terminal in preparation of tachykinin antagonist |
| 08/07/2013 | CN103230587A Composition of crocodile hemoglobin peptide and preparation method of composition |
| 08/07/2013 | CN103230586A Application of recombinant human thymosin alpha protein to preparation of drugs for wound healing |
| 08/07/2013 | CN103230585A Polygeline dextran composition |
| 08/07/2013 | CN103230584A Cobalt, copper, selenium, traditional Chinese medicine element, and vitamin leucoderma-treating external medicinal liquor |
| 08/07/2013 | CN103230583A Animal norfloxacin nicotinate compound injection for treating intestinal diseases and preparation method of injection |
| 08/07/2013 | CN103230582A Enramycin premix preparation method |
| 08/07/2013 | CN103230581A Composition and method for treating traumatic brain injury |
| 08/07/2013 | CN103230014A Composition capable of increasing bone mineral density |
| 08/07/2013 | CN102631666B Preparation method for biological agent for preventing and controlling human papilloma virus infection |
| 08/07/2013 | CN102603886B Mutant fibroblast growth factor and use thereof in treating endocrine diseases |
| 08/07/2013 | CN102505034B Method for preparing active polypeptide from corn protein powder |
| 08/07/2013 | CN102416170B Production process of multienzyme pieces |
| 08/07/2013 | CN102397525B Chinese medicinal composition with function of improving nutritional anemia and preparation method thereof |
| 08/07/2013 | CN102319216B Insulin liposome lyophilized powder, oral insulin compound preparation and preparation methods and applications thereof |
| 08/07/2013 | CN101880315B Branch oligopeptide with analgesic activity, preparation method and application thereof |
| 08/07/2013 | CN101808655B Peptides derived from plasminogen activator inhibitor-1 and uses thereof |
| 08/07/2013 | CN101745102B Composition of 5-aminolevulinic acid and derivative thereof as well as application thereof |
| 08/07/2013 | CN101631552B Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions |
| 08/07/2013 | CN101563100B Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 08/07/2013 | CN101389642B Cyclic antimicrobial peptides |
| 08/07/2013 | CN101066446B Chinese medicine composition for treating enteritis |
| 08/06/2013 | US8501914 Recombinant protein S composition |
| 08/06/2013 | US8501913 Spider mite silk proteins |
| 08/06/2013 | US8501912 Filipil compositions and methods for treating cancer |
| 08/06/2013 | US8501909 Polypeptides having affinity for HER2 |
| 08/06/2013 | US8501908 Immunogenic peptides |
| 08/06/2013 | US8501907 Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |